← FDA Drug Approvals (Drugs@FDA)
LIFITEGRAST
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM INDS LTD · Approved 2023-01-11
Drug application
- FDA Application #
ANDA215126- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LIFITEGRAST
- Generic name
- Lifitegrast
- Active ingredients
- LIFITEGRAST
- Dosage form
- SOLUTION/DROPS
- Route
- OPHTHALMIC
- Marketing status
- None (Tentative Approval)
- Sponsor
- SUN PHARM INDS LTD
- First approval
- 2023-01-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown